GILDER GAGNON HOWE & CO LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$341,955
-23.2%
9,592
-0.6%
0.01%
-16.7%
Q2 2023$445,062
+47.9%
9,648
+91.1%
0.01%
+20.0%
Q2 2022$301,000
-38.6%
5,048
-25.2%
0.01%0.0%
Q1 2022$490,000
-58.5%
6,751
-51.9%
0.01%
-28.6%
Q4 2021$1,180,000
-27.6%
14,034
-22.3%
0.01%
-12.5%
Q3 2021$1,629,000
-6.9%
18,060
-1.5%
0.01%
-11.1%
Q2 2021$1,749,000
-16.5%
18,344
-0.2%
0.01%
-18.2%
Q1 2021$2,094,000
-35.0%
18,388
-21.0%
0.01%
-31.2%
Q4 2020$3,223,000
+564.5%
23,284
+240.4%
0.02%
+100.0%
Q3 2016$485,000
+44.8%
6,840
-0.0%
0.01%
+14.3%
Q2 2016$335,000
-22.8%
6,842
-0.2%
0.01%
-22.2%
Q1 2016$434,0000.0%6,855
+61.9%
0.01%
+50.0%
Q2 2015$434,000
-2.5%
4,235
-40.9%
0.01%0.0%
Q1 2015$445,000
+38.6%
7,162
-2.2%
0.01%
+20.0%
Q4 2014$321,000
-25.0%
7,324
-3.2%
0.01%
-16.7%
Q3 2014$428,000
+25.5%
7,567
-0.3%
0.01%
+20.0%
Q2 2014$341,000
-65.6%
7,589
-62.6%
0.01%
-64.3%
Q1 2014$992,00020,2910.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders